Simplex Trading’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-201
Closed 10096
2024
Q1
$0 Buy
201
+149
+287% +$162 ﹤0.01% 10200
2023
Q4
$0 Sell
52
-1,228
-96% -$1.64K ﹤0.01% 10112
2023
Q3
$2K Buy
1,280
+1,261
+6,637% +$3.05K ﹤0.01% 8205
2023
Q2
$0 Sell
19
-446
-96% -$1.66K ﹤0.01% 10207
2023
Q1
$1K Buy
465
+52
+13% +$214 ﹤0.01% 8828
2022
Q4
$1K Buy
+413
New +$2.28K ﹤0.01% 8984
2022
Q2
Sell
-101
Closed -$881 11387
2022
Q1
$1K Buy
+101
New +$1.75K ﹤0.01% 10184

Other funds holding BTCY

Simplex Trading's BTCY Position: Q2 2024 in Review

Simplex Trading sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2024, closing a stake of 201 shares.

Simplex Trading first reported a position in BTCY in Q1 2022 and held it in 7 quarters. The position peaked at $2K in Q3 2023. 22 funds tracked by Wall St. Rank hold BTCY as of Q2 2024.

  • Simplex Trading reported no remaining Biotricity, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 201 Biotricity, Inc. Common Stock shares in Q2 2024.
  • Simplex Trading first reported a position in Biotricity, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Simplex Trading's Biotricity, Inc. Common Stock position peaked at $2K in Q3 2023.
  • 22 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.